Conference
EFFICACY AND SAFETY OF AGOMELATINE (25-50 MG/DAY) VERSUS ESCITALOPRAM (10-20 MG/DAY) IN SEVERE GENERALIZED ANXIETY DISORDER
Authors
Stein D; Khoo J-P; Van Ameringen M; Hoschl C; Ahokas A; Bauer M; Bitter I; Jarema M; Mosolov SN; Vavrusova L
Volume
52
Pagination
pp. 136-137
Publisher
SAGE PUBLICATIONS LTD
Publication Date
April 1, 2018
Conference proceedings
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
ISSN
0004-8674